FilingSEC EDGAR8-K
XBiotech Appoints Jan-Paul Simard as Co-CEO
· SEC accepted
StageAppointment
Filing content
The company appointed Jan-Paul Simard as Co-CEO effective October 23 and entered into an employment agreement including a grant of 2 million stock options.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…